Product Information

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $6.1105 per EA under NDC 33342028607. Its NADAC has been published 89 times since Mar 5, 2025.

FDA first approved this application on Jan 7, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB

amlodipine,valsartan and hydrochlorothiazide
$6.1105per EA

Strength

10; 25; 160 mg/1; mg/1; mg/1

NDC

33342028607

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207299

FDA Approved

1/7/2025

TE Code

AB

On Market Since

1/6/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has been published 89 times since Mar 5, 2025, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.

Current price$6.1105 per EA
All-time high$8.3788 (Oct 15, 2025)
All-time low$5.9684 (Jul 22, 2026)
52-week high$8.1145
52-week low$5.9684
Median price$7.4656
Average price$7.3406
Largest weekly change-6.8% (May 20, 2026)
Weeks tracked89
Tracking sinceMar 5, 2025

Price History

1W

0.0%

1M

+0.4%

3M

+2.4%

6M

-16.5%

1Y

-25.7%

3Y

N/A

5Y

N/A

All

-17.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine,valsartan and hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $6.1105 per EA (NDC 33342028607), effective Nov 11, 2026.

How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has declined 17.8%. It has been tracked across 89 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?

Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has ranged from a low of $5.9684 (Jul 22, 2026) to a high of $8.3788 (Oct 15, 2025), with a median of $7.4656 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB (NDC 33342028607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.